Nootropic Raw Powder NSI-189

Nootropic Raw Powder NSI-189 Treatments For Major Depressive Disorder (MDD) CAS:1270138-40-3

Just try a small order to start our cooperation, we will NOT make you down !
Any products interested pls let me know I will give info.in details.
[email protected]
Skype:live:kathelin_4
WhataApp:+8618872220706

NSI-189 is a nootropic and neurogenic research chemical derived from nicotinamide and pyrazine created by Neuralstem, Inc. Research into NSI-189 has been heavily funded by the Defense Advanced Research Projects Agency (DARPA) and theNational Institutes of Health (NIH).

NSI-189 Spec.
Product Name:NSI-189
Synonyms:NSI-189;[2-[(3-Methylbutyl)amino]-3-pyridinyl][4-(phenylmethyl)-1-piperazinyl];[2-[(3-Methylbutyl)amino]-3-pyridinyl][4-(phenylmethyl)-1-piperazinyl]NSI189;NSI-189 [2-[(3-Methylbutyl)amino]-3-pyridinyl][4-(phenylmethyl)-1-piperazinyl];NSI-189, >=98%;(4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]
CAS:1270138-40-3
MF:C22H30N4O
MW:366.4998

Abstract
the Food and Drug Administration (FDA) have approved the advance to Phase 1b in the ongoing clinical trial to test its neuroregenerative compound, NSI-189.
NSA-189 is a proprietary new chemical entity that stimulates new neuron growth in the hippocampus, an area of the brain believed to be contributory in MDD and other conditions, such as Alzheimer's disease and Post-traumatic stress disorder (PTSD).  Phase 1b of the clinical trial is to test the safety and tolerability of the drug in depressed patients.